King Altace Physician Promotion Emphasized For 2001; DTC Delayed To 2002

King Pharmaceuticals will dedicate its entire $90 mil. Altace marketing campaign to physician-directed promotions following deferment of the ACE inhibitor's DTC advertising campaign.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet